Analysis of non-HLA genomic risk factors in HLA-matched unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia

Background Allogeneic hematopoietic cell transplantation is the main curative therapy for patients with chronic myeloid leukemia who do not respond to tyrosine kinase inhibitors. It has been proposed that non-human leukocyte antigen gene polymorphisms influence outcome after hematopoietic cell trans...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Kim F. Pearce, Stephanie J. Lee, Michael Haagenson, Effie W. Petersdorf, Jean Norden, Matthew P. Collin, John P. Klein, Stephen R. Spellman, Shelagh A. Lowerson, Stella Davies, Anne M. Dickinson
Format: Artykuł
Język:English
Wydane: Ferrata Storti Foundation 2012-07-01
Seria:Haematologica
Dostęp online:https://haematologica.org/article/view/6344